Prestige Consumer Healthcare Inc. $PBH Shares Purchased by Profund Advisors LLC

Profund Advisors LLC grew its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 356.2% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 33,690 shares of the company’s stock after buying an additional 26,305 shares during the quarter. Profund Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $1,545,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Vise Technologies Inc. purchased a new stake in shares of Prestige Consumer Healthcare in the third quarter worth about $250,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Prestige Consumer Healthcare during the 3rd quarter worth approximately $216,000. Choreo LLC lifted its position in Prestige Consumer Healthcare by 14.8% during the 3rd quarter. Choreo LLC now owns 20,376 shares of the company’s stock worth $935,000 after acquiring an additional 2,632 shares in the last quarter. Pinnacle Wealth Planning Services Inc. lifted its position in Prestige Consumer Healthcare by 69.3% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,153 shares of the company’s stock worth $53,000 after acquiring an additional 472 shares in the last quarter. Finally, Leeward Investments LLC MA boosted its holdings in Prestige Consumer Healthcare by 20.3% in the 3rd quarter. Leeward Investments LLC MA now owns 526,609 shares of the company’s stock worth $24,156,000 after acquiring an additional 88,693 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Wall Street Analyst Weigh In

PBH has been the subject of several analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 22nd. Zacks Research lowered Prestige Consumer Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 29th. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Hold” and a consensus price target of $67.67.

View Our Latest Analysis on PBH

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH opened at $49.78 on Tuesday. The firm’s 50 day moving average is $48.51 and its two-hundred day moving average is $54.12. The company has a current ratio of 3.23, a quick ratio of 1.99 and a debt-to-equity ratio of 1.06. The firm has a market capitalization of $2.36 billion, a P/E ratio of 10.81, a PEG ratio of 1.50 and a beta of 0.34. Prestige Consumer Healthcare Inc. has a 52 week low of $42.62 and a 52 week high of $71.07.

Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.98 EPS for the quarter, beating the consensus estimate of $0.89 by $0.09. Prestige Consumer Healthcare had a net margin of 15.57% and a return on equity of 11.39%. The firm had revenue of $265.71 million for the quarter, compared to analysts’ expectations of $253.02 million. During the same quarter last year, the company earned $0.90 EPS. Prestige Consumer Healthcare’s quarterly revenue was up 6.5% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. Analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.56 earnings per share for the current year.

About Prestige Consumer Healthcare

(Free Report)

Prestige Consumer Healthcare Inc (NYSE: PBH) is a consumer healthcare company that develops, acquires, markets and distributes over-the-counter health and wellness products. Its portfolio is focused on established brands designed to address everyday healthcare needs, including digestive health, eye and ear care, oral care, pain relief, cold and allergy symptoms, feminine care and dermatological conditions.

The company’s brands include Dramamine and Bonine for motion-sickness relief; BC and Goody’s for pain relief; Clear Eyes and Murine for eye and ear care; Chloraseptic for sore-throat relief; Compound W for wart removal; Fleet for gastrointestinal health; and Summer’s Eve for feminine care.

Further Reading

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.